Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01238913
Other study ID # Benign esophageal lesions
Secondary ID
Status Withdrawn
Phase N/A
First received November 5, 2010
Last updated September 29, 2015
Start date September 2015
Est. completion date September 2015

Study information

Verified date September 2015
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The evaluation of using metal stents as medically indicated for the treatment of benign esophageal lesions.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date September 2015
Est. primary completion date September 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Subject is 18 years or older

2. Subject has medical indication to undergo endoscopic placement of esophageal metal stent

3. Subject must be able to give informed consent

Exclusion Criteria:

1. Any contraindications for endoscopic placement of esophageal metal stent

2. The subject is unable to give informed consent.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Endoscopy
Endoscopic placement of an esophageal metal stent as per medical indication.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Florida

Outcome

Type Measure Description Time frame Safety issue
Primary Successful stenting of Benign esophageal lesions This is an observational study to determine the effectiveness of stenting benign esophageal lesions with a metal stent. approximately 2-3 hours No
See also
  Status Clinical Trial Phase
Completed NCT01337206 - SX ELLA Esophageal Degradable BD Stent System N/A